Misclassification of coffee consumption data and the development of a standardised coffee unit measure ‌ Paul Roderick, Sean Ewings, Robin Poole, Julie Parkes, Jonathan A Fallowfield

Ստացեք ամբողջական տեքստը

A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease ‌ Maria Jimenez Ramos, Timothy J. Kendall, Ignat Drozdov, Jonathan A. Fallowfield

Ստացեք ամբողջական տեքստը

Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records ‌ Ignat Drozdov, Benjamin Szubert, Ian A. Rowe, Timothy J. Kendall, Jonathan A. Fallowfield

Ստացեք ամբողջական տեքստը

All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study ‌ Oliver J. Kennedy, Jonathan A. Fallowfield, Robin Poole, Peter C. Hayes, Julie Parkes, Paul J. Roderick

Ստացեք ամբողջական տեքստը

Reliable computational quantification of liver fibrosis is compromised by inherent staining variation ‌ Stuart Astbury, Jane I Grove, David A Dorward, Indra N Guha, Jonathan A Fallowfield, Timothy J Kendall

Ստացեք ամբողջական տեքստը

A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP) ‌ Fiona J. Gifford, Philip D. J. Dunne, Graeme Weir, Hamish Ireland, Catriona Graham, Sharon Tuck, Peter C. Hayes, Jonathan A. Fallowfield

Ստացեք ամբողջական տեքստը

Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease ‌ Rohit Sinha, Khalida A. Lockman, Natalie Z.M. Homer, Edward Bower, Paul Brinkman, Hugo H. Knobel, Jonathan A. Fallowfield, Alan J. Jaap, Peter C. Hayes, John N. Plevris

Ստացեք ամբողջական տեքստը

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis ‌ Andrea Dennis, Matt D. Kelly, Carolina Fernandes, Sofia Mouchti, Jonathan A. Fallowfield, Gideon Hirschfield, Michael Pavlides, Michael Pavlides, Michael Pavlides, Stephen Harrison, Stephen Harrison, Manu V. Chakravarthy, Rajarshi Banerjee, Arun Sanyal

Ստացեք ամբողջական տեքստը

Study protocol: HepaT1ca – an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies ‌ Damian J. Mole, Jonathan A. Fallowfield, Timothy J. Kendall, Fenella Welsh, Scott I. Semple, Velicia Bachtiar, Matt Kelly, Stephen J. Wigmore, O. James Garden, Henry R. Wilman, Rajarshi Banerjee, Myrddin Rees, Michael Brady

Ստացեք ամբողջական տեքստը

Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study ‌ Anna M. Hoy, Natasha McDonald, Ross J. Lennen, Matteo Milanesi, Amy H. Herlihy, Timothy J. Kendall, William Mungall, Michael Gyngell, Rajarshi Banerjee, Robert L. Janiczek, Philip S. Murphy, Maurits A. Jansen, Jonathan A. Fallowfield

Ստացեք ամբողջական տեքստը

Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabet... ‌ Sheila M. Grecian, Stela McLachlan, Jonathan A. Fallowfield, Peter C. Hayes, Indra Neil Guha, Joanne R. Morling, Stephen Glancy, Rachel M. Williamson, Rebecca M. Reynolds, Brian M. Frier, Nicola N. Zammitt, Jackie F. Price, Mark W. J. Strachan

Ստացեք ամբողջական տեքստը

Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer. ‌ Damian J Mole, Jonathan A Fallowfield, Ahmed E Sherif, Timothy Kendall, Scott Semple, Matt Kelly, Gerard Ridgway, John J Connell, John McGonigle, Rajarshi Banerjee, J Michael Brady, Xiaozhong Zheng, Michael Hughes, Lucile Neyton, Joanne McClintock, Garry Tucker, Hilary Nailon, Dilip Patel, Anthony Wackett, Michelle Steven, Fenella Welsh, Myrddin Rees, HepaT1ca Study Group

Ստացեք ամբողջական տեքստը

Genome‐Wide Association Study of NAFLD Using Electronic Health Records ‌ Cameron J. Fairfield, Thomas M. Drake, Riinu Pius, Andrew D. Bretherick, Archie Campbell, David W. Clark, Jonathan A. Fallowfield, Caroline Hayward, Neil C. Henderson, Peter K. Joshi, Nicholas L. Mills, David J. Porteous, Prakash Ramachandran, Robert K. Semple, Catherine A. Shaw, Cathie L.M. Sudlow, Paul R.H.J. Timmers, James F. Wilson, Stephen J. Wigmore, Ewen M. Harrison, Athina Spiliopoulou

Ստացեք ամբողջական տեքստը

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. ‌ Victoria K Snowdon, Neil J Lachlan, Anna M Hoy, Patrick W F Hadoke, Scott I Semple, Dilip Patel, Will Mungall, Timothy J Kendall, Adrian Thomson, Ross J Lennen, Maurits A Jansen, Carmel M Moran, Antonella Pellicoro, Prakash Ramachandran, Isaac Shaw, Rebecca L Aucott, Thomas Severin, Rajnish Saini, Judy Pak, Denise Yates, Neelesh Dongre, Jeremy S Duffield, David J Webb, John P Iredale, Peter C Hayes, Jonathan A Fallowfield

Ստացեք ամբողջական տեքստը